QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nadrash, T A. Articles by Delate, T. Search for Related Content PubMed PubMed Citation Articles by Nadrash, T A. Articles by Delate, T.

GERIATRICS

Clinical Pharmacists' Role in Improving Osteoporosis Treatment Rates Among Elderly Patients with Untreated Atraumatic Fractures

Clinical Pharmacy Specialist in Primary Care, Kaiser Permanente Colorado—Arapahoe Medical Office, Centennial, CO

Susyn Lynn Plushner, PharmD BCPS

Clinical Pharmacy Specialist in Rheumatology, Kaiser Permanente Colorado—Franklin Medical Office; Clinical Assistant Professor, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO

Thomas Delate, PhD MS

Clinical Research Scientist, Kaiser Permanente Colorado—Central Support Services, Aurora, CO

Reprints: Dr. Nadrash, Kaiser Permanente Arapahoe Medical Office, Clinical Pharmacy Services, 5555 E. Arapahoe Rd., Centennial, CO 80122, fax 303/850-2022, Theda.Ann.Nadrash{at}kp.org

BACKGROUND: Missed opportunities for osteoporosis detection and treatment following fractures, especially in the elderly, are common. Clinical pharmacy specialist (CPS) intervention may positively impact this deficiency.

OBJECTIVE: To examine the impact of a CPS-managed intervention to identify, screen, and initiate appropriate osteoporosis pharmacotherapy in elderly patients after an atraumatic fracture.

METHODS: This was a prospective quality improvement analysis. Hospitalized and ambulatory patients who had a diagnosis of atraumatic fracture between July 2002 through August 2003 but were not on osteoporosis pharmacotherapy were identified by CPSs. Bone mineral density (BMD) screening and osteoporosis pharmacotherapy recommendations were made by a CPS when appropriate. Descriptive analyses were performed to determine the proportion of patients initiated on osteoporosis pharmacotherapy or receiving a recommended BMD evaluation.

RESULTS: A total of 137 (40 inpatient and 97 ambulatory) female patients were included. The mean ages ± SD of inpatient and ambulatory patients were 83 ± 8 and 78 ± 7 years, respectively. Overall, 50% (n = 69) of patients either initiated their recommended osteoporosis pharmacotherapy (48% [n = 19] and 30% [n = 29] of inpatient and ambulatory patients, respectively) or received a recommended BMD screening (42 ambulatory patients were recommended and 50% [n = 21] completed a BMD test). Of the patients who completed a BMD test, 17 (81%) were osteoporotic. All 17 were initiated on osteoporosis pharmacotherapy.

CONCLUSIONS: Using a systematic approach to identify patients in need of osteoporosis pharmacotherapy, a CPS-managed intervention resulted in clinically meaningful osteoporosis treatment initiation rates.

Key Words: atraumatic fracture, osteoporosis, pharmacist intervention

Published Online, February 26, 2008. www.theannals.com, DOI 10.1345/aph.1K541

This article has been cited by other articles:

				L. N Hall, S. P Shrader, and K. R Ragucci Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic Ann. Pharmacother., November 1, 2009; 43(11): 1781 - 1786. [Abstract] [Full Text] [PDF]